Company intelligence / Profile preview

SelasBio

San Francisco, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

SelasBio identifies and supports early-stage medical entrepreneurs and technologies that address unmet needs in defense healthcare. The company provides early funding, leverages Department of Defense pathways such as SBIR/STTR grants, and offers expertise in productization and commercialization to bring innovative solutions to market. Their model focuses on translating cutting-edge research into scalable products with both military and broader societal applications.

Therapeutic areas: Other
Modalities: Not specified; company is a platform/accelerator for medical technologies rather than a therapeutic developer itself
Industry: Investors

Partnerships

Works closely with U.S. Department of Defense programs such as SBIR/STTR for funding opportunities

Beyond the preview

Go deeper on SelasBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SelasBio.

Explore the full profile